Dr. Alexander Fanaroff and Dr. C. Michael Gibson Discuss: Effect Of Gamification, Financial Incentives Or Both Combined To Increase Physical Activity Among Patients With Elevated Risk For Major Adverse Cardiovascular Events. The Be Active Randomized Clinical Trial April 7, 2024 Disclosures: TBD
Dr. C. Michael Gibson and Dr. Serge Korjian Discuss: CSL112 (Apolipoprotein A-I) Infusions And Cardiovascular Outcomes In Patients With Acute Myocardial Infarction (ApoA-I Event Reducing In Ischemic Syndromes II (AEGIS-II) Trial): Primary Trial Results April 6, 2024 Disclosures: TBD
Dr. Javed Butler and Dr. C. Michael Gibson Discuss: Empagliflozin After Acute Myocardial Infarction: Results Of The EMPACT-MI Trial April 6, 2024 Disclosures: TBD
Dr. Gregg Stone and Dr. C. Michael Gibson Discuss: A Double-blind, Randomized Placebo Procedure-controlled Trial Of An Interatrial Shunt In Patients With HfrEF And HfpEF: Principal Results From The RELIEVE-HF Trial April 6, 2024 Disclosures: TBD
Dr. Josep Rodés-Cabau and Dr. C. Michael Gibson Discuss: Trancatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis and Small Aortic Annuli: A Randomized Clinical Trial (the VIVA Trial) October 26, 2023 Disclosures: TBD
Dr. Susheel K. Kodali and Dr. C. Michael Gibson Discuss: TRISCEND II: A Randomized Trial of Transcatheter Tricuspid Valve Replacement in Patients with Severe Tricuspid Regurgitation October 26, 2023 Disclosures: TBD
Dr. Matthias Götberg and Dr. C. Michael Gibson Discuss: Long-term Clinical Outcomes After iFR vs. FFR Guided Coronary Revascularization – Insights From the SWEDEHEART National Registry October 25, 2023 Disclosures: TBD
Dr. Myeong-Ki Hong Presents: Less Than 1-Month Dual Antiplatelet Therapy Followed by Ticagrelor Monotherapy After Coronary Drug-Eluting Stent Implantation for Acute Coronary Syndrome: A Randomized Trial October 25, 2023 Disclosures: TBD
Dr. Roberto Galea and Dr. C. Michael Gibson Discuss: One-Year Outcomes after Amulet or Watchman/FLX Device for Percutaneous Left Atrial Appendage Closure: a Pre-Specified Analysis of the SWISS-APERO Randomized Clinical Trial October 24, 2023 Disclosures: TBD
Dr. Michael J. Reardon and Dr. C. Michael Gibson Discuss: Four-Year Outcomes From the EVOLUT Low Risk Trial October 24, 2023 Disclosures: TBD
